Ovali F, Samanci N, Ermiş B, Akdoğan Z, Dağoğlu T
Department of Obstetrics and Gynecology, Istanbul Faculty of Medicine, Istanbul University, Turkey.
Vox Sang. 1998;74(3):198-200. doi: 10.1046/j.1423-0410.1998.7430198.x.
This study was performed to test whether corticosteroids were superior to intravenous immunoglobulins (IVIG) in the treatment of neonatal autoimmune thrombocytopenia (NAT).
All cases received IVIG, and unresponsive cases received corticosteroids.
Of 7 babies who received IVIG, only 1 responded. The 6 remaining cases received corticosteroids thereafter, and all of them responded well to this therapy.
Corticosteroids may be more effective than IVIG in NAT.
本研究旨在测试皮质类固醇在治疗新生儿自身免疫性血小板减少症（NAT）方面是否优于静脉注射免疫球蛋白（IVIG）。
所有病例均接受IVIG治疗，无反应的病例接受皮质类固醇治疗。
在接受IVIG治疗的7名婴儿中，只有1名有反应。其余6例随后接受了皮质类固醇治疗，所有这些病例对该治疗反应良好。
在新生儿自身免疫性血小板减少症中，皮质类固醇可能比IVIG更有效。
